Skip to main content

Horizons Marijuana Life Sciences ETF(HMMJ-T)
TSX

Today's Change
Real-Time Last Update

Closing Bell: Horizons Marijuana Life Sciences ETF up on Wednesday (HMMJ)

Automated Summaries - The Globe and Mail - Wed Mar 27, 4:02PM CDT

In trading today, shares of Horizons Marijuana Life Sciences ETF opened at $10.84 and closed at $11.20. It traded at a low of $10.73 to a high of $11.20.

Share prices raised 3.90% from the previous day's close of $10.78.

Today across North America, the TSX Composite closed -0.14% at 21912.52, the S&P 500 closed -0.28% at 5203.58, the Dow Jones Industrial Average closed -0.08% at 39282.33 and the Nasdaq Composite closed -0.42% at 16315.70.

Horizons Marijuana Life Sciences ETF has listed on the Toronto Stock Exchange (TSX) under the ticker HMMJ.

A total of 28,233 shares was traded during the last trading day, with total trades of 140, while having an average volume of 27,618 over the last 5-days.

The TSX market on the whole today saw 3,990 price advancers against 1,258 declines and 113 unchanged.

During the prior 52 weeks, HMMJ.TO has traded as high as $11.61 (September 12,2023) and low as $8.07 (October 27,2023). Moreover, the shares have advanced 4.97% in the last year, while in 2024, they have boosted 20.56%.

Following today's trading, Horizons Marijuana Life Sciences ETF has a market capitalization of $89.65 million on a float of 8,316 shares outstanding. Its annual EPS is $None.

Horizons Marijuana Life Sciences ETF is a None company headquartered in, None.

The Horizons Marijuana Life Sciences Index ETF seeks to replicate, to the extent possible, the performance of the North American Marijuana Index, net of expenses. The Index is designed to provide exposure to the performance of a basket of North American publicly listed life sciences companies with significant business activities in the marijuana industry..

Currently, Horizons Marijuana Life Sciences ETF's consensus rating is "Strong Sell" based on 0 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe